MSB:ASX
Mesoblast Ltd
A$1.77
arrow_upward
+0.11%(+0.0020) 1D
Oct 20, 12:02:57 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MSB...
Open
A$1.77
High
A$1.82
Low
A$1.75
Mkt. cap
2.31B
Avg. vol.
3.20M
Volume
2.28M
52-wk high
A$3.31
52-wk low
A$1.74
EPS
-A$0.06
Shares outstanding
1.30B
No. of employees
108
Open
A$1.77
High
A$1.82
Low
A$1.75
Mkt. cap
2.31B
Avg. vol.
3.20M
Volume
2.28M
52-wk high
A$3.31
52-wk low
A$1.74
EPS
-A$0.06
Shares outstanding
1.30B
No. of employees
108
News stories
From web sources and news partners
Kalkine
·
13 hours ago
Mesoblast Limited (ASX:MSB): Ryoncil Revenue and Operating Cash Trends in Focus
Seeking Alpha
·
15 hours ago
Mesoblast: Ryoncil Helps Fund Rexlemestrocel-L For Back Pain (NASDAQ:MESO)
Kalkine
·
19 hours ago
Mesoblast Limited (ASX:MSB): Ryoncil Revenue, FY26 Results and Cell Therapy Pipeline
Simply Wall Street
·
3 days ago
Will Ryoncil Revenue Growth Change Mesoblast Stock Narrative
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd